Literature DB >> 23812935

Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvest.

Robert N Lown1, Sameer Tulpule, Nigel H Russell, Charles F Craddock, Rochelle Roest, J Alejandro Madrigal, Bronwen E Shaw.   

Abstract

Approximately 1 in 20 unrelated donors are asked to make a second donation of hematopoietic progenitor cells, the majority for the same patient. Anthony Nolan undertook a study of subsequent hematopoietic progenitor cell donations made by its donors from 2005 to 2011, with the aims of predicting those donors more likely to be called for a second donation, assessing rates of serious adverse reactions and examining harvest yields. This was not a study of factors predictive of second allografts. During the study period 2591 donations were made, of which 120 (4.6%) were subsequent donations. The median time between donations was 179 days (range, 21-4016). Indications for a second allogeneic transplant included primary graft failure (11.7%), secondary graft failure (53.2%), relapse (30.6%) and others (1.8%). On multivariate analysis, bone marrow harvest at first donation was associated with subsequent donation requests (odds ratio 2.00, P=0.001). The rate of serious adverse reactions in donors making a subsequent donation appeared greater than the rate in those making a first donation (relative risk=3.29, P=0.005). Harvest yields per kilogram recipient body weight were equivalent between donations, although females appeared to have a lower yield at the subsequent donation. Knowledge of these factors will help unrelated donor registries to counsel their donors.

Entities:  

Mesh:

Year:  2013        PMID: 23812935      PMCID: PMC3856971          DOI: 10.3324/haematol.2013.088971

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  33 in total

Review 1.  Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation.

Authors:  S N Wolff
Journal:  Bone Marrow Transplant       Date:  2002-04       Impact factor: 5.483

2.  Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes.

Authors:  K Kishi; S Takahashi; H Gondo; S Shiobara; A Kanamaru; S Kato; N Hirabayashi; Y Moriyama; M Harada; S Asano; H Hara; A Shibata
Journal:  Bone Marrow Transplant       Date:  1997-03       Impact factor: 5.483

3.  Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections.

Authors:  P Anderlini; J Lauppe; D Przepiorka; D Seong; R Champlin; M Körbling
Journal:  Br J Haematol       Date:  1997-02       Impact factor: 6.998

4.  Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation.

Authors:  A Bosi; D Laszlo; M Labopin; J Reffeirs; M Michallet; E Gluckman; P E Alessandrino; F Locatelli; J P Vernant; J Sierra; J P Jouet; F Frassoni
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

5.  Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

Authors:  R E Champlin; N Schmitz; M M Horowitz; B Chapuis; R Chopra; J J Cornelissen; R P Gale; J M Goldman; F R Loberiza; B Hertenstein; J P Klein; E Montserrat; M J Zhang; O Ringdén; S C Tomany; P A Rowlings; M E Van Hoef; A Gratwohl
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

6.  Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.

Authors:  M Eapen; S A Giralt; M M Horowitz; J P Klein; J E Wagner; M-J Zhang; M S Tallman; D I Marks; B M Camitta; R E Champlin; O Ringdén; C N Bredeson; R Martino; R P Gale; M S Cairo; M R Litzow; M deLima
Journal:  Bone Marrow Transplant       Date:  2004-10       Impact factor: 5.483

7.  Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields.

Authors:  Javier De la Rubia; Cristina Arbona; Consuelo Del Cañizo; Rosario Arrieta; Felipe De Arriba; María J Pascual; Isabel Sanjuan; Miguel A Díaz; Salut Brunet; Adrián Alegre; Andrés Insunza; Ildefonso Espigado; Concha Zamora; Javier De la Serna; David Serrano; Joan Bargay; José Petit; Dobleta Martínez; Amparo Verdeguer; José M Ribera; Carmen Martínez; Luis Benlloch; Miguel A Sanz
Journal:  J Hematother Stem Cell Res       Date:  2002-08

8.  Effects on donors of second bone marrow collections.

Authors:  D F Stroncek; P McGlave; N Ramsay; J McCullough
Journal:  Transfusion       Date:  1991 Nov-Dec       Impact factor: 3.157

9.  Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.

Authors:  Michael A Pulsipher; Pintip Chitphakdithai; Brent R Logan; Bronwen E Shaw; John R Wingard; Hillard M Lazarus; Edmund K Waller; Matthew Seftel; David F Stroncek; Angela M Lopez; Dipnarine Maharaj; Peiman Hematti; Paul V O'Donnell; Alison W Loren; Susan F Leitman; Paolo Anderlini; Steven C Goldstein; John E Levine; Willis H Navarro; John P Miller; Dennis L Confer
Journal:  Blood       Date:  2012-10-29       Impact factor: 22.113

10.  Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.

Authors:  J P Radich; J E Sanders; C D Buckner; P J Martin; F B Petersen; W Bensinger; G B McDonald; M Mori; G Schoch; J A Hansen
Journal:  J Clin Oncol       Date:  1993-02       Impact factor: 44.544

View more
  2 in total

1.  Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations.

Authors:  Sandhya R Panch; Brent Logan; Jennifer A Sees; Stephanie Bo-Subait; Bipin Savani; Nirali N Shah; Jack W Hsu; Galen Switzer; Hillard M Lazarus; Paolo Anderlini; Peiman Hematti; Dennis Confer; Michael A Pulsipher; Bronwen E Shaw; David F Stroncek
Journal:  Transplant Cell Ther       Date:  2021-03-09

Review 2.  Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations.

Authors:  Irene Riezzo; Natascha Pascale; Raffaele La Russa; Arcangelo Liso; Monica Salerno; Emanuela Turillazzi
Journal:  Stem Cells Int       Date:  2017-06-07       Impact factor: 5.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.